Tutorials
STU:H7T2 (Hong Kong)  
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd

€ 4.70 (0%) Aug 12
P/E:
At Loss
P/B:
3.00
Market Cap:
€ 2.30B ($ 2.36B)
Enterprise V:
€ 1.50B ($ 1.54B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
2.30B
Market Cap $:
2.36B
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value €:
1.50B
Enterprise Value $:
1.54B
PB Ratio:
3.00
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

HUTCHMED (China) Ltd
NAICS : 325412
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
Description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.

Financials (Next Earnings Date:2022-11-01 Est.)

STU:H7T2's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 131.426
EPS (TTM) (€) -0.116
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 4.703
12-1 Month Momentum % 0
52-Week Range (€) 4.703 - 4.703
Shares Outstanding (Mil) 864.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HUTCHMED (China) Ltd Filings

Document Form Filing Date
No Filing Data